NorthWest Biotherapeutics Inc (NWBO)

[drugrunner]

anders-- your projection of price is only based on US.. IT APPEARS.

add in Europe and ROW OF WORLD..

you are looking at a minimum of 50-100k potential patients worldwide for just GBM..

THE EXPONENTIAL rise in market cap occurs with off label use initially for all solid tumors.. it will take 5-7 years to get approval for all tumors

the rate limiting factor is producing enough of the personalized vaccine.

IF THIS IS A TRULY GENERATIONAL DRUG.. eventual KEYTRUDA LIKE SALES....

then 2-3-5B is way too low of a projection for market cap..